Bain Capital
http://www.baincapital.comBain Capital, LLC is a global private investment firm that manages several pools of capital including private equity, venture capital, public equity and leveraged debt assets with more than $65 billion in assets under management. Since its inception in 1984, Bain Capital has made private equity investments and add-on acquisitions in more than 300 companies in a variety of industries around the world, and has a team of almost 300 professionals dedicated to investing in and supporting its portfolio companies, including such leading companies as Dunkin' Donuts, Michaels Stores and Domino's Pizza. Headquartered in Boston, Bain Capital has offices in New York, London, Munich, Hong Kong, Shanghai and Tokyo.
View Older Stories View More Recent Stories
-
/C O R R E C T I O N -- VISO TRUST/
-
Almaviva and OverIT team up on Field Service digital transformation in the Infrastructure and Transportation sector
-
Exclusive-Kioxia market value set at $5 billion, Japan chipmaker to receive listing approval, sources say
-
StoryCatch Partners Acquires EmpiraMed
-
Flex (FLEX) to Join S&P MidCap 400; Azenta (AZTA) and Concentra Group Holdings (CON) to Join S&P SmallCap 600
-
Flex Set to Join S&P MidCap 400; Azenta and Concentra Group Holdings to Join S&P SmallCap 600
-
Veza Recognized as a CRN® 2024 Stellar Startup!
-
Form 8-K Bain Capital Private For: Nov 13
-
Edward Woodford, Founder and CEO of Zero Hash recognized as 2025 Chicago Titan 100
-
Arc Launches First AI Platform For $2 Trillion Private Credit Industry
-
BW Fusion, Biodyne, and Agronomy 365 Join to Revolutionize Agriculture Industry, Supported by Bain Capital Double Impact
-
Gather AI Expands Inventory Intelligence Solution into Freezer & Cold Storage Warehouse Environments
-
Canapi Ventures Welcomes New Principals Kristie Han and Connie Qian
-
AVCJ announces Asian Private Equity & Venture Capital Awards 2024 winners
-
B Capital Appoints Timur Akazhanov as General Partner
-
Bain Capital Closes Global Special Situations Fund
-
Aggie Makes Social Media Not Suck
-
Alkeus Pharmaceuticals Receives FDA Rare Pediatric Disease and Fast Track Designations for Gildeuretinol as a Treatment for Stargardt Disease
-
Form SC 13D/A Mersana Therapeutics, Filed by: Bain Capital Life Sciences Fund II, L.P.
-
Form D/A Bain Capital Public Equi
-
KKR Receives Support and Recommendation from FUJI SOFT for Second Tender Offer and Expects to Launch Tender Offer Next Week
-
KKR raises tender offer price for Fuji Soft acquisition
-
Form SC 13G/A NaaS Technology Inc. Filed by: Bain Capital Rise Education IV Cayman Ltd
-
Form SC 13G/A Disc Medicine, Inc. Filed by: Bain Capital Life Sciences Opportunities III, LP
-
Form SC 13G/A Xilio Therapeutics, Inc. Filed by: Bain Capital Life Sciences Fund II, L.P.
-
Form SC 13G/A BRP Inc. Filed by: Bain Capital Integral Investors II, L.P.
-
Form SC 13G/A Annexon, Inc. Filed by: Bain Capital Life Sciences Fund, L.P.
-
Form SC 13G/A AvidXchange Holdings, Filed by: BAIN CAPITAL VENTURE FUND 2014, L.P.
-
Form SC 13G/A Syros Pharmaceuticals, Filed by: Bain Capital Life Sciences Fund II, L.P.
-
Form 10-Q Bain Capital Private For: Sep 30
-
Form 13F-HR BAIN CAPITAL INVESTORS For: Sep 30
-
Form 13F-HR BAIN CAPITAL VENTURE For: Sep 30
-
Form 13F-NT Bain Capital Partners For: Sep 30
-
Form 13F-NT Bain Capital Partners For: Sep 30
-
Form 13F-NT Bain Capital Venture For: Sep 30
-
Form 13F-NT Bain Capital Fund XI, For: Sep 30
-
Form 13F-NT BAIN CAPITAL VENTURE For: Sep 30
-
Form 13F-NT BAIN CAPITAL VENTURE For: Sep 30
-
Form 13F-NT Bain Capital Venture For: Sep 30
-
Form 13F-NT Bain Capital Fund XII, For: Sep 30
-
Form 13F-NT Bain Capital Life Scienc For: Sep 30
-
Form 13F-NT Bain Capital Life Scienc For: Sep 30
-
Form 13F-NT Bain Capital Life Scienc For: Sep 30
-
Form 13F-NT Bain Capital Life Scienc For: Sep 30
-
Form 13F-NT Bain Capital Life Scienc For: Sep 30
-
Form 13F-NT Bain Capital Life Scienc For: Sep 30
-
Form 13F-NT Bain Capital Life Scienc For: Sep 30
-
Form 13F-HR Bain Capital Life Scienc For: Sep 30
-
Form 13F-NT Bain Capital Life Scienc For: Sep 30
-
Form 13F-HR Bain Capital Public Equi For: Sep 30
